These success, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 aid the idea of concentrating on ACKR3 as a singular approach to modulate the opioid technique, which could open new therapeutic avenues for opioid-linked disorders.A research study released in Anesthesiology an